Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Drugs 78(11):11131132 dAquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, et al (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
Similar content being viewed by others Introduction Around 2040% of patients with type 2 diabetes have chronic kidney disease (CKD), defined by either reduced kidney function, the presence of albuminuria, or other evidence of kidney damage [1,2,3,4]
Structures of GLP1, liraglutide & semaglutide
doi: 10.1186/s12885-018-4570-8 217 ZhangYXuFLiangHCaiMWenXLiXet al
US$ 20.33
US$ 23.41
US$ 21.09
US$ 22.17
US$ 27.93
US$ 25.37
